Sulfasalazine Induced DRESS Syndrome: A Review of Case Reports
Jasmeen ., Pawan Krishan, Sudhir Varma, Harpreet Kalra, Kanchan Vohra
Journal of Advances in Medicine and Medical Research · pp. 1–11 · Published 6 Oct 2015
10.9734/BJMMR/2016/20558Abstract
Introduction: Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) is designated as a lethal adverse drug effect with characteristic sign and symptoms such as skin rashes, fever, leukocytosis with eosinophilia or atypical lymphocytes, lymph node enlargement, and liver or renal dysfunction. Incidences of the DRESS range from 1/1000-1/10,000 drug exposures and are associated with a mortality rate of 10%. Pathogenesis of DRESS relates to an abnormal immune response in a genetically vulnerable individual, i.e. presence of human leukocyte antigen (HLA)*5801 and HLA-B* 5701 genotype and slow acetylation metabolic pathways. Methods: 48 cases were associated with the “Sulfasalazine-induced DRESS syndrome” reported between January 1990- March 2015 in PubMed-MEDLINE and HighWire Press. The “RegiSCAR” scoring system was used to analyze the case reports. Using this system, cases were classified into 4 categories as “no”, “possible, “probable” and “definite”. Results: The vast majority of cases were classified as “probable/definite” DRESS cases (83%). Hypereosinophilia, atypical lymphocytes and fever were significantly associated with “probable/ definite” DRESS cases. Liver involvement and skin rash was described in almost all of the cases, including “possible cases”. DRESS was found fatal in two cases. Conclusion: Awareness of DRESS is essential for diagnosis with the presence of skin rash, liver involvement, fever, hyper eosinophilia and lymphadenopathy. Early identification, followed by a prompt withdrawal of the culprit drug is the most essential measure to avoid disease evolution and to restore wellness.
Cited by 10
I. Zouaki, F. Lairani, H. Aouroud · Cureus · 2025
Natalija Aleksandrova, Jonas De Rop, F. Camu · International Journal of Emergency Medicine · 2024
Nattanicha Chaisrimaneepan, Corley Pruneda, Marwan Elmassry · Clinical Case Reports · 2024
A. Sil, Monideepa Bhattacharjee, Atanu Chandra · BMJ Case Reports · 2021
David R. Mack, E. Benchimol, J. Critch · Gastroenterology · 2019
D. Mack, E. Benchimol, J. Critch · Journal of the Canadian Association of Gastroenterology · 2018
M. Lang, J. Fish, C. Covelli · British journal of hospital medicine · 2017
Marwan H. Adwan · Current Rheumatology Reports · 2017
Danilo Kuzman, Biljana Jeremić-Gajinov, Dunja Vesković · Hospital Pharmacology · 2023
Natalija Aleksandrova, Jonas De Rop, Frederic Camu · 2024
Related research
- Effective Management of Voriconazole-Induced Multi-Organ Dysfunction and Septic Shock Using CytoSorb-Integrated Continuous Renal Replacement Therapy: A Case Report — shares topic coverage
- Pattern of Adverse Drug Reaction to Antiepileptic Drugs at a Tertiary Hospital in North-Central Nigeria: A Prospective Observational Study — shares topic coverage
- Centre-based Evaluation of Some Biochemical Effects of the Initial Phase of Anti-tuberculosis Therapy in Bayelsa State — shares topic coverage
- An Overview of Pharmacovigilance and Adverse Drug Reaction Monitoring of Drugs and Vaccines during the COVID-19 Pandemic — shares topic coverage
- Practices and Barriers towards Pharmacovigilance and Adverse Drug Reporting among Intern Pharmacists in Nigeria — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
10
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.